These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 19617654

  • 21. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B, Barthélémy S, Saurini F, Hamon M, Thiébot MH.
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [Abstract] [Full Text] [Related]

  • 22. Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates.
    Foltin RW, Haney M.
    Pharmacol Biochem Behav; 2007 Apr; 86(4):766-73. PubMed ID: 17445873
    [Abstract] [Full Text] [Related]

  • 23. Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum.
    Donnerer J, Liebmann I.
    Pharmacology; 2018 Apr; 101(5-6):330-336. PubMed ID: 29627825
    [Abstract] [Full Text] [Related]

  • 24. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B.
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [Abstract] [Full Text] [Related]

  • 25. Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol.
    Biała G, Budzyńska B.
    Pharmacol Rep; 2010 Dec; 62(5):797-807. PubMed ID: 21098863
    [Abstract] [Full Text] [Related]

  • 26. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
    Bilir KA, Anli G, Ozkan E, Gunduz O, Ulugol A.
    Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
    [Abstract] [Full Text] [Related]

  • 27. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
    Naderi N, Haghparast A, Saber-Tehrani A, Rezaii N, Alizadeh AM, Khani A, Motamedi F.
    Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213
    [Abstract] [Full Text] [Related]

  • 28. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
    Rubio M, Fernández-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA.
    Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats.
    Chen SF, Hsu WC, Lu XY, Chuang CY, Liao RM.
    Psychopharmacology (Berl); 2022 May; 239(5):1459-1473. PubMed ID: 34741633
    [Abstract] [Full Text] [Related]

  • 32. The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.
    Fukuda H, Abe T, Yoshihara S.
    Int Arch Allergy Immunol; 2010 May; 152(3):295-300. PubMed ID: 20150748
    [Abstract] [Full Text] [Related]

  • 33. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.
    Pamplona FA, Prediger RD, Pandolfo P, Takahashi RN.
    Psychopharmacology (Berl); 2006 Nov; 188(4):641-9. PubMed ID: 16947018
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR.
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [Abstract] [Full Text] [Related]

  • 36. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
    Izzo AA, Mascolo N, Capasso R, Germanò MP, De Pasquale R, Capasso F.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
    [Abstract] [Full Text] [Related]

  • 37. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
    Brzózka MM, Fischer A, Falkai P, Havemann-Reinecke U.
    Behav Brain Res; 2011 Apr 15; 218(2):280-7. PubMed ID: 21070814
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG.
    Br J Pharmacol; 2007 Mar 15; 150(5):613-23. PubMed ID: 17245363
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.